FENC

NASD Fennec Pharmaceuticals Inc.
Oct 12, 2026 · 9:53 PM ET EOD Market Closed

$10.72 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.72, $0.11 below the day’s high of $10.83

YTD change
+39.22%
vs 20-day SMA
+0.86%
vs 200-day SMA
+19.08%

Price ranges

Previous day
$10.57 $10.86
open $10.66 close $10.71
+$0.05 (+0.47%)
Today
$10.42 $10.83
open $10.68 now $10.72
+$0.04 (+0.37%)
Past week
$10.01 $10.86
from $10.20 now $10.72
+$0.52 (+5.10%)
Past month
$10.01 $11.31
from $10.96 now $10.72
-$0.24 (-2.19%)
This year
$5.65 $13.25
from $7.70 now $10.72
+$3.02 (+39.22%)

Price & Performance

+4.79 (+80.78%) / 6M

$5.38$8.03$10.68$13.33Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 28.5% away from all-time highs of $14.99
  • FENC is up 39% since the beginning of the year
  • FENC is up 25% over the past 12 months
  • FENC is down 2% over the past 1 month
  • 8% of all FENC investors are betting against FENC

FENC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +27.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.11
Earnings momentum +257.1% Quarterly EPS growth
Quarterly change +257.1%

Valuation

P/E ratio N/A
Enterprise value $238.1M
Beta 1.28

Balance sheet & scale

IncomeN/A
Revenue$33.9M
Cash$18.7M
Debt$18.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $376.0M

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $417.57 +0.65%
MRNA Moderna, Inc. $213.74 -5.00%
RVMD Revolution Medicines, Inc. $193.95 +2.21%
ROIV Roivant Sciences Ltd. $34.59 -2.40%
BNTX BioNTech SE Sponsored ADR $95.84 -1.16%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.